JET Enhanced Thrombectomy Intervention
JET Enhanced Thrombectomy Intervention
Evaluate real world patient outcomes after treatment of acute and non-acute upper and lower
 extremity venous and arterial thrombosis with the JETi Thrombectomy System.
The JETi Registry is an open label, prospective, non-randomized, multi-center observational
 registry including 250 patients who meet eligibility from up to 30 sites worldwide. Patient
 participation will be 12 months including post procedure follow-up contact at 10 days, 3, 6
 and 12 months. The study duration is estimated at 36 months.
Inclusion Criteria:

 -  Patient has been treated for acute/sub-acute thrombosis in the peripheral vascular
 system with any of the JETi® Peripheral Thrombectomy System Catheters

 -  Patient has provided appropriate consent/authorization per the site's institutional
 policy and procedure.

 -  Age ≥ 18 years.

 Exclusion Criteria:

 -  Patient has previously been enrolled in JETi Registry in the last 12 months.

 -  Current participation in another drug or device trial.